Peer reviewed paper on Virustatic® antiviral materials

Biological Cloth Face Coverings—The Reduction of SARS-CoV-2 and Influenza (H1N1) Infectivity by Viruferrin® Treatment

Viruferrin® treated fabrics experienced a >99% SARS-CoV-2 virus reduction after five minutes of contact.

To read the peer reviewed paper on the antiviral efficacy of Virustatic® developed materials, click the link:

Medina-Magües ES, Stedman A, Hope P, Osorio JE. Biological Cloth Face Coverings—The Reduction of SARS-CoV-2 and Influenza (H1N1) Infectivity by Viruferrin™ Treatment. Materials. 2021; 14(9):2327.

Previous
Previous

Biofilms funding hat-trick for Virustatic

Next
Next

Virustatic selected for BFTT’s prestigious award to accelerate sustainable innovation